Influence of extracorporeal membrane oxygenation on the pharmacokinetics of ceftolozane/tazobactam: an ex vivo and in vivo study

Ceftolozane-tazobactam pharmacokinetics during extracorporeal membrane oxygenation in a lung transplant recipient

(2019) Fabio Arena et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oxygenator Impact on Ceftolozane and Tazobactam in Extracorporeal Membrane Oxygenation Circuits

(2019) Jeffrey J. Cies et al.   Pediatric Critical Care Medicine

PORCINE PREDICTION OF PHARMACOKINETIC PARAMETERS IN PEOPLE: A PIG IN A POKE?

(2018) Huadong Tang et al.   DRUG METABOLISM AND DISPOSITION

Ex Vivo Model to Decipher the Impact of Extracorporeal Membrane Oxygenation on Beta-lactam Degradation Kinetics

(2017) Cyril Leven et al.   THERAPEUTIC DRUG MONITORING

Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature

(2016) Jennifer Sherwin et al.   CLINICAL THERAPEUTICS

β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case–control study

(2015) Katia Donadello et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Ceftolozane/tazobactam pharmacokinetic/pharmacodynamic-derived dose justification for phase 3 studies in patients with nosocomial pneumonia

(2015) Alan J. Xiao et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Impact of MIC Range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the CeftolozaneIn VivoPharmacokinetic/Pharmacodynamic Target

(2014) A. J. Lepak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population pharmacokinetics of ceftolozane/tazobactam in healthy volunteers, subjects with varying degrees of renal function and patients with bacterial infections

(2014) Gurudatt Chandorkar et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Extracorporeal Membrane Oxygenation in Cardiopulmonary Disease in Adults

(2014) Darryl Abrams et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012)

(2013) David J. Farrell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VivoActivities of Ceftolozane, a New Cephalosporin, with and without Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, Including Strains with Extended-Spectrum β-Lactamases, in the Thighs of Neutropenic Mice

(2012) W. A. Craig et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Swine as Models in Biomedical Research and Toxicology Testing

(2011) M. M. Swindle et al.   VETERINARY PATHOLOGY

PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel

(2010) Yong Zhang et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Determinants of drug absorption in different ECMO circuits

(2010) E. D. Wildschut et al.   INTENSIVE CARE MEDICINE